Skip to content

BioSig Technologies, Inc. STEX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$506.66M-9.5%-$462.76M-1,061%-$39.85M-52.2%-$26.18M-169%-$9.72M+5.9%
$5M+41.6%$3.53M+68.8%$2.09M+229%$636K+385%$131K-30.3%
$80.4M+40.8%$57.1M+589%$8.29M-7.5%$8.96M+11.7%$8.02M+14.5%
-$19.5M-86.8%-$10.44M-32.3%-$7.89M-81.1%-$4.36M+4.5%-$4.56M+4.2%
$45.36M
$8.05M
$48.54M-11.5%$54.88M+203%$18.1M+285%$4.7M-40.3%$7.87M+67.1%
$4.04M-80.8%$21.08M+85.9%$11.34M+599%$1.62M-51.0%$3.31M+6,998%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does BioSig Technologies, Inc. generate?
BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
Where does BioSig Technologies, Inc.'s cash flow data come from?
Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.